For DSS, the higher expression of IGF2BP3 had a worse DSS in a subgroup of WHO grade: G3, a subgroup of IDH status: WT, a subgroup of IDH status: Mut, a subgroup of 1p/19q codeletion: non−codel, a subgroup of Primary therapy outcome: PD, a subgroup of Primary therapy outcome: SD, a subgroup of Gender: Female, a subgroup of Gender: Male, a subgroup of Race: Black or African American, a subgroup of Race: White, a subgroup of Age: <=60, a subgroup of Age: >60, a subgroup of Histological type: Astrocytoma, and Histological type: Oligoastrocytoma (Supplementary Figures 5A–M). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).